195 related articles for article (PubMed ID: 34861059)
41. MiR-126 on mice with coronary artery disease by targeting S1PR2.
Fan JL; Zhang L; Bo XH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):893-904. PubMed ID: 32016996
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic utility of circulating plasma microRNA-101a in severity of coronary heart disease.
Yu H; Tu YF; Liu HM; Xu ME
Ir J Med Sci; 2021 Nov; 190(4):1391-1396. PubMed ID: 33474702
[TBL] [Abstract][Full Text] [Related]
43. Elevated serum miR-3129-5p contributes to the progression of coronary heart disease via targeting mTOR.
Wang ZY; Zhao T; Zhou J; Gao F
Kaohsiung J Med Sci; 2021 Apr; 37(4):314-323. PubMed ID: 33336524
[TBL] [Abstract][Full Text] [Related]
44. Circulating tumor necrosis factor-α, interleukin-1β, and interleukin-17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients.
Guo J; Hu Z; Ren L; Zhao W; Zuo R; Guo S; Jia C; Gao W
J Clin Lab Anal; 2023 Mar; 37(5):e24853. PubMed ID: 36877748
[TBL] [Abstract][Full Text] [Related]
45. Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus.
Li Q; Zhang Z; Du R; Hu X; Yan Y; Gao Q; Fan Y
J Pediatr Endocrinol Metab; 2012; 25(7-8):711-6. PubMed ID: 23155698
[TBL] [Abstract][Full Text] [Related]
46. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
[TBL] [Abstract][Full Text] [Related]
47. Correlation of microRNA-146a/b with disease risk, biochemical indices, inflammatory cytokines, overall disease severity, and prognosis of sepsis.
Chen L; Yu L; Zhang R; Zhu L; Shen W
Medicine (Baltimore); 2020 May; 99(22):e19754. PubMed ID: 32481361
[TBL] [Abstract][Full Text] [Related]
48. Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease.
Wang W; Li Z; Zheng Y; Yan M; Cui Y; Jiang J
Lipids Health Dis; 2019 Jan; 18(1):22. PubMed ID: 30670045
[TBL] [Abstract][Full Text] [Related]
49. Correlation of Blood and Intestinal Mucosa miR-34a Expressions with Disease Severity in Ulcerative Colitis Patients.
Li YL; Cai CQ; Shi XL; Xu XF; Guo LJ
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747908
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of long non-coding RNA myocardial infarction-associated transcription is correlated with coronary artery stenosis and elevated inflammation in patients with coronary atherosclerotic heart disease.
Yan ZS; Zhang NC; Li K; Sun HX; Dai XM; Liu GL
Kaohsiung J Med Sci; 2021 Dec; 37(12):1038-1047. PubMed ID: 34558803
[TBL] [Abstract][Full Text] [Related]
51. Association of Exosomal miR-34a with Markers of Dyslipidemia and Endothelial Dysfunction in Children and Adolescents with T1DM.
Ibrahim AA; Wahby AA; Ashmawy I; Saleh RM; Soliman H
J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):401-409. PubMed ID: 32654473
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke.
Li P; Duan S; Fu A
J Clin Lab Anal; 2020 Feb; 34(2):e23056. PubMed ID: 31721299
[TBL] [Abstract][Full Text] [Related]
53. Protective Effects of Microrna-22 Against Endothelial Cell Injury by Targeting NLRP3 Through Suppression of the Inflammasome Signaling Pathway in a Rat Model of Coronary Heart Disease.
Huang WQ; Wei P; Lin RQ; Huang F
Cell Physiol Biochem; 2017; 43(4):1346-1358. PubMed ID: 28992621
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of microRNA-429 alleviates myocardial injury of rats with coronary heart disease.
Yang Q; Li J; Zhang H; Zuo H; Zhang Q; Cheng J
Cell Cycle; 2019 Oct; 18(19):2550-2565. PubMed ID: 31438762
[TBL] [Abstract][Full Text] [Related]
55. MiR-34a may Function as Potential Biomarker for Remission after Traumatic Spinal Cord Injury.
Cai B; Gu H; Yang H
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255309
[TBL] [Abstract][Full Text] [Related]
56. Circulating pro-angiogenic micro-ribonucleic acid in patients with coronary heart disease.
Zhang H; Hao J; Sun X; Zhang Y; Wei Q
Interact Cardiovasc Thorac Surg; 2018 Sep; 27(3):336-342. PubMed ID: 29608698
[TBL] [Abstract][Full Text] [Related]
57. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
[TBL] [Abstract][Full Text] [Related]
58. Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions.
Luo M; Wang G; Xu C; Zeng M; Lin F; Wu J; Wan Q
Life Sci; 2019 Dec; 239():117092. PubMed ID: 31760103
[TBL] [Abstract][Full Text] [Related]
59. Catechin Attenuates Coronary Heart Disease in a Rat Model by Inhibiting Inflammation.
Tu S; Xiao F; Min X; Chen H; Fan X; Cao K
Cardiovasc Toxicol; 2018 Oct; 18(5):393-399. PubMed ID: 29464499
[TBL] [Abstract][Full Text] [Related]
60. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis.
Wang F; Long G; Zhao C; Li H; Chaugai S; Wang Y; Chen C; Wang DW
J Transl Med; 2013 Sep; 11():222. PubMed ID: 24053180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
